ALIVUS LIFE SCIENCES
Back to Income Statement
|
ALIVUS LIFE SCIENCES Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,552 Cr | ₹2,387 Cr | ₹2,283 Cr | ₹2,161 Cr | ₹2,123 Cr |
What is the latest Revenue of ALIVUS LIFE SCIENCES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,552 Cr |
| Mar2025 | ₹2,387 Cr |
| Mar2024 | ₹2,283 Cr |
| Mar2023 | ₹2,161 Cr |
| Mar2022 | ₹2,123 Cr |
How is Revenue of ALIVUS LIFE SCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,552 Cr | 6.91 | |
| Mar2025 | ₹2,387 Cr | 4.54 | |
| Mar2024 | ₹2,283 Cr | 5.64 | |
| Mar2023 | ₹2,161 Cr | 1.79 | |
| Mar2022 | ₹2,123 Cr | - | |
Compare Revenue of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹17,640.0 Cr | -1% | 13.2% | 53.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -1% |
13.2% |
53.2% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses